electroCore, Inc. (ECOR) Reports Q3 Loss, Misses Revenue Estimates

Impact · against what's priced in

electroCore (ECOR) reports a mixed Q3 result with a significant earnings beat but a double-digit revenue miss. While the reduction in quarterly loss to $0.13 per share is positive, the revenue shortfall suggests headwinds in top-line growth despite 11.5% year-over-year increases.

ECOR−0.10

No priced-in read yet

In context

The company beat earnings estimates with a loss of $0.13 per share against a predicted $0.26, but missed revenue estimates by 13.48%, posting $9.69 million.

Read from the article alone

• pharmaceuticals
• earnings
• healthcare
• biotech
• fundamental analysis
• ECOR
• earnings surprise
• revenue miss

Search tags